Articles by Disease (Parkinsonian Disorders)

Perspectives and New Aspects of Metalloproteinases’ Inhibitors in the Therapy of CNS Disorders: From Chemistry to Medicine

Journal: Current Medicinal Chemistry
Volume: 26
Page: 3208-3224
Author(s): Anna Boguszewska-Czubara*, Barbara Budzynska, Krystyna Skalicka-Wozniak and Jacek Kurzepa

Neuroprotective Methodologies of Co-Enzyme Q10 Mediated Brain Hemorrhagic Treatment: Clinical and Pre-Clinical Findings

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 18
Page: 446-465
Author(s): Kajal Rajdev and Sidharth Mehan*

Comparison of Mono-dopaminergic and Multi-target Pharmacotherapies in Primary Parkinson Syndrome and Assessment Tools to Evaluate Motor and Non-motor Symptoms

Journal: Current Drug Therapy
Volume: 14
Page: 124-134
Author(s): Felix-Martin Werner* and Rafael Coveñas

Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside

Journal: Current Neuropharmacology
Volume: 17
Page: 861-873
Author(s): Marika Alborghetti and Ferdinando Nicoletti*

Recent Advances and Novel Approaches for Nose to Brain Drug Delivery for Treatment of Migraine

Journal: Drug Delivery Letters
Volume: 9
Page: 182-198
Author(s): Nidhi Sachan, Shiv Bahadur* and Pramod K. Sharma

Mitochondria-Targeted Drugs

Journal: Current Molecular Pharmacology
Volume: 12
Page: 202-214
Author(s): Roman A. Zinovkin* and Andrey A. Zamyatnin*

Safety and Efficacy of Levetiracetam for the Management of Levodopa- Induced Dyskinesia in Patients with Parkinson’s Disease: A Systematic Review

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 18
Page: 317-325
Author(s): Mahmoud A. Ebada*, Souad Alkanj, Mohamed Ebada, Ahmed H. Abdelkarim, Ahmed Diab, Mohamed A.E. Aziz, Ahmed M. Soliman, Notila Fayed, Eshak I. Bahbah and Ahmed Negida

Astragaloside IV Supplementation Promotes A Neuroprotective Effect in Experimental Models of Neurological Disorders: A Systematic Review

Journal: Current Neuropharmacology
Volume: 17
Page: 648-665
Author(s): Ianara M. Costa, Francisca O.V. Lima, Luciana C.B. Fernandes, Bianca Norrara, Francisca I. Neta, Rodrigo D. Alves, José R.L.P. Cavalcanti, Eudes E.S. Lucena, Jeferson S. Cavalcante, Amalia C.M. Rego, Irami A. Filho, Dinalva B. Queiroz, Marco A.M. Freire and Fausto P. Guzen*

The Low Molecular Weight Brain-derived Neurotrophic Factor Mimetics with Antidepressant-like Activity

Journal: Current Pharmaceutical Design
Volume: 25
Page: 729-737
Author(s): Tatiana A. Gudasheva*, Polina Povarnina, Alexey V. Tarasiuk and Sergey B. Seredenin

The Impact of Natural Compounds on the Treatment of Neurodegenerative Diseases

Journal: Current Organic Chemistry
Volume: 23
Page: 335-360
Author(s): Lorane I. da S. Hage-Melim*, Jaderson V. Ferreira, Nayana K.S. de Oliveira, Lenir C. Correia, Marcos R.S. Almeida, João G.C. Poiani, Carlton A. Taft and Carlos H.T. de Paula da Silva